Trial Profile
Phase I/II trial of chemoradiotherapy concurrent with S-1 and cisplatin in patients with clinical stage II/III esophageal carcinoma (JCOG0604).
Status:
Discontinued
Phase of Trial:
Phase I/II
Latest Information Update: 26 May 2016
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Cisplatin
- Indications Oesophageal cancer
- Focus Adverse reactions; Therapeutic Use
- 14 May 2013 Planned end date changed from 1 Aug 2012 to 1 Aug 2014 as reported by University Hospital Medical Information Network - Japan.
- 03 Dec 2011 Planned End Date changed from 1 Mar 2010 to 1 Aug 2012 as reported by University Hospital Medical Information Network - Japan record.
- 03 Dec 2011 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.